![Thomas Kündig](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 690 000 $ al 31/08/2026
Thomas M Kündig is the founder of Saiba Animal Health AG (Switzerland), founded in 2013, holding the title of Chief Medical Officer since 2013.
Current jobs include Independent Director at XBiotech, Inc. starting in 2025, Director at UniversitätsSpital Zürich, and Professor at the University of Zurich.
Education history includes a doctorate from the University of Zurich.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
XBIOTECH, INC. 0,98 % | 02/10/2026 | 300.000 ( 0,98 % ) | 690 000 $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| XBIOTECH INC. | Director/Miembro de la Junta | 24/06/2025 |
UniversitätsSpital Zürich
 UniversitätsSpital Zürich Hospital/Nursing ManagementHealth Services Operates a hospital | Director/Miembro de la Junta | - |
University of Zurich
 University of Zurich Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| Empresas | Cargo | Fin |
|---|---|---|
Saiba Animal Health AG
 Saiba Animal Health AG BiotechnologyHealth Technology Develops novel therapeutic medicines to address chronic diseases in pets | Fundador | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
XBiotech, Inc.
 XBiotech, Inc. BiotechnologyHealth Technology Engages in the discovery and development of therapeutic antibodies | Health Technology |
University of Zurich
University of Zurich Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UniversitätsSpital Zürich
UniversitätsSpital Zürich Hospital/Nursing ManagementHealth Services Operates a hospital | Health Services |
Saiba Animal Health AG
Saiba Animal Health AG BiotechnologyHealth Technology Develops novel therapeutic medicines to address chronic diseases in pets | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
